Koninklijke Philips NV (XAMS:PHIA) Short-term investments

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XAMS:PHIA Koninklijke Philips NV XAMS:PHIA
73 GF Score
Price €21.72
GF Value €22.83
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Koninklijke Philips NV Short-term investments?

Short-term investments only applies to insurance companies.

XAMS:PHIA
73GF Score
Koninklijke Philips NV XAMS:PHIA
Short-term investments is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Koninklijke Philips NV (XAMS:PHIA) Overvalued in 2026?

Based on GuruFocus' analysis, Koninklijke Philips NV stock appears to be undervalued. The current stock price of €21.72 is trading 4.9% below its estimated GF Value™ of €22.83. GuruFocus considers Koninklijke Philips NV to be Fairly Valued.

Key valuation signals for XAMS:PHIA:

  • Short-term investments:
  • GF Value™: €22.83 vs. price of €21.72 (4.9% below fair value)
  • GF Score™: 73/100 with 2 warning signs

No single metric tells the full story. See the XAMS:PHIA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Koninklijke Philips NV Business Description

Address Prinses Irenestraat 59, Amsterdam, NLD, 1077 WV
Koninklijke Philips NV is a Dutch health technology company focused on medical devices and personal health products. Its largest segment, Diagnosis & Treatment, provides imaging systems such as MRI, CT and ultrasound, X-ray equipment, and image-guided therapy solutions for hospitals and clinics. The Connected Care segment offers patient monitoring, hospital informatics, and sleep and respiratory care products, including ventilators and sleep therapy devices. Personal Health sells consumer products such as electric toothbrushes, shavers, and grooming appliances through retail channels. Philips serves healthcare providers, patients, and consumers worldwide, with significant revenue from North America, Europe, and growth markets in Asia. The company generates revenue primarily through equipment sales, recurring service contracts, software and informatics subscriptions, and consumer retail sales. Philips has divested most of its former lighting and consumer electronics businesses to concentrate on health technology.
73GF Score

Get the complete analysis for XAMS:PHIA

Short-term investments is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€21.72
Price
€22.83
GF Value